Imatinib 400 mg Tablet

Description

Product Overview

Imatinib 400 mg Tablet is a trusted medication designed to manage and treat certain types of cancers effectively. Known for its targeted action, Imatinib 400 mg Tablet plays a significant role in inhibiting cancer cell growth. It is a key component in ongoing cancer care regimens.

Uses

• Treatment of chronic myeloid leukemia (CML).
• Management of acute lymphoblastic leukemia (ALL).
• Therapy for gastrointestinal stromal tumors (GISTs).
• Control of dermatofibrosarcoma protuberans (DFSP).
• Reduction of tumor size in certain myelodysplastic/myeloproliferative diseases.

Key Benefits

• Effectively targets cancer cells while minimizing impact on healthy cells.
• Reduces tumor size and proliferation effectively.
• Proven efficacy in prolonging survival rates in specific cancers.
• Improves quality of life by managing symptoms and disease progression.
• Supports integrated cancer care with minimal interference in daily activities.

Dosage & Administration

Imatinib 400 mg Tablet should be taken orally, once daily with a meal and a full glass of water to enhance absorption and reduce gastrointestinal discomfort. Dosage may vary based on the specific condition being treated, patient response, and medical advice. It is crucial to follow your healthcare provider’s instructions closely and not to adjust the dosage without consultation.

Side Effects

While Imatinib 400 mg Tablet is generally well-tolerated, some patients may experience side effects. Common side effects include nausea, vomiting, muscle cramps, and fatigue. Most side effects are manageable and temporary, but any severe or persistent symptoms should be reported to a healthcare professional immediately to ensure proper management and adjustment of treatment if necessary.

Precautions

Individuals with liver or kidney impairment should use Imatinib 400 mg Tablet with caution, under close medical supervision. Pregnant or breastfeeding women should discuss potential risks and benefits with their doctor before starting treatment. It is important for patients to inform their healthcare provider of all medications and supplements they are taking to avoid potential interactions. Regular monitoring and follow-ups are essential to ensure the safety and effectiveness of the treatment.